Malta vs Small island developing States (SIDS): Proportion of the target population who received the final dose of
Malta
80.0%
in 2024
Small island developing States (SIDS)
22.0%
in 2024
Malta rank
23rd
Small island developing States (SIDS) rank
25th
Proportion of the target population who received the final dose of over time
- Malta
- Small island developing States (SIDS)
How they compare
Malta currently reports 80.0% against 22.0% in Small island developing States (SIDS), a difference of 58.0%.
That makes Malta's figure about 3.6 times Small island developing States (SIDS)'s.
Across all 12 years both countries report, Malta has been ahead every year.
Malta ranks 23rd and Small island developing States (SIDS) ranks 25th of 107 countries.
Malta has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Malta | Small island developing States (SIDS) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 81.4% | 5.1% | 76.3% | Malta |
| 2020s | 82.8% | 13.2% | 69.6% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Malta or Small island developing States (SIDS)?
- Malta, at 80.0% against 22.0% in Small island developing States (SIDS) as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Malta and Small island developing States (SIDS)?
- 58.0%, with Malta ahead.
- How many years of comparable data are there for Malta and Small island developing States (SIDS)?
- 12 years are reported by both, from 2013 to 2024.
- How do Malta and Small island developing States (SIDS) rank globally for proportion of the target population who received the final dose of?
- Malta ranks 23rd and Small island developing States (SIDS) ranks 25th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.